Targeting FMRP: A new window for cancer immunotherapy

Targeting FMRP: A new window for cancer immunotherapy

Saved in:

Bibliographic Details
Main Authors:	Yaguang Zhang, Tong Wu, Junhong Han
Format:	Article
Language:	English
Published:	Wiley 2023-04-01
Series:	MedComm
Online Access:	https://doi.org/10.1002/mco2.233
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Immunotherapies to Nano-Immunotherapies: Advances in Immune Targeting in Bladder Cancer
by: Beatriz Ramos, et al.
Published: (2025-02-01)

Nanomaterials in cancer immunotherapy: targeting cancer-associated fibroblasts
by: Zhongsong Zhang, et al.
Published: (2025-01-01)

Molecular switch of the dendrite-to-spine transport of TDP-43/FMRP-bound neuronal mRNAs and its impairment in ASD
by: Pritha Majumder, et al.
Published: (2025-01-01)

A new paradigm for cancer immunotherapy: targeting immunogenic cell death-related noncoding RNA
by: Guojuan Sun, et al.
Published: (2025-01-01)

MicroRNAs as Immunotherapy Targets for Treating Gastroenterological Cancers
by: Yixin Yang, et al.
Published: (2018-01-01)

Treating Penile Cancer in the Immunotherapy and Targeted Therapy Era
by: Gavin Hui, et al.
Published: (2019-01-01)

Interferon Lambda: A New Sword in Cancer Immunotherapy
by: Ahmed Lasfar, et al.
Published: (2011-01-01)

Biometallic ions and derivatives: a new direction for cancer immunotherapy
by: Lin Zhao, et al.
Published: (2025-01-01)

Immunogenic Targets for Specific Immunotherapy in Multiple Myeloma
by: Lu Zhang, et al.
Published: (2012-01-01)

Efficacy of natural killer T and gammadelta T cells in mesothelin-targeted immunotherapy of pancreatic cancer
by: Yuankui Zhu, et al.
Published: (2025-02-01)

Identification of TUBB3 as an immunotherapy target in lung cancer by genome wide in vivo CRISPR screening
by: Dan Zhao, et al.
Published: (2025-02-01)

Targeting Innate Immune Cells for Immunotherapy
by: Leandro J. Carreño, et al.
Published: (2017-01-01)

A covalent peptide-based lysosome-targeting protein degradation platform for cancer immunotherapy
by: Youmei Xiao, et al.
Published: (2025-02-01)

Unveiling the role of SYNGR4 in breast cancer development: a novel target for immunotherapy
by: Jie Ma, et al.
Published: (2025-01-01)

Improving ferroptosis-mediated immunotherapy for colorectal cancer through lysosome-targeted photodynamic therapy
by: Zhian Chen, et al.
Published: (2025-04-01)

Recent advances in immunotherapy targeting CETP proteins for atherosclerosis prevention
by: Wenhui Hu, et al.
Published: (2025-12-01)

Mitochondria-targeted photothermal-chemodynamic therapy enhances checkpoint blockade immunotherapy on colon cancer
by: Benchao Zheng, et al.
Published: (2025-04-01)

Targeting SRSF1 improves cancer immunotherapy by dually acting on CD8+T and tumor cells
by: Gui-Qi Zhu, et al.
Published: (2025-01-01)

Advances in Immunotherapy and Targeted Therapy of Malignant Melanoma
by: Xue Wang, et al.
Published: (2025-01-01)

Gastroenterological Cancer and Immunotherapy
by: Xiaoping Wang, et al.
Published: (2018-01-01)

CSF3R as a potential prognostic biomarker and immunotherapy target in glioma
by: Minglei Huang, et al.
Published: (2024-06-01)

Editorial: Ovarian cancer targeted medication: PARP inhibitors, anti-angiogenic drugs, immunotherapy, and more, volume II
by: Zhi-Bin Wang, et al.
Published: (2025-02-01)

Targeted therapy and immunotherapy for gastric cancer: rational strategies, novel advancements, challenges, and future perspectives
by: Dong Luo, et al.
Published: (2025-02-01)

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gynecologic cancer
by: Anne Mills, et al.
Published: (2023-06-01)

Targeting T-Cell Activation for Malaria Immunotherapy: Scoping Review
by: Balsa Nobility Gustifante, et al.
Published: (2025-01-01)

Identification of TTLL8, POTEE, and PKMYT1 as immunogenic cancer-associated antigens and potential immunotherapy targets in ovarian cancer
by: Esen Yonca Bassoy, et al.
Published: (2025-12-01)

Novel Cancer Immunotherapies and Antitumor Immunity
by: Lei Zhao, et al.
Published: (2019-01-01)

Cancer Immunotherapy: Theory and Application
by: Guobing Chen, et al.
Published: (2018-01-01)

Immunotherapy in Recurrent Ovarian Cancer
by: Keyao Chen, et al.
Published: (2025-01-01)

Dynamic roles of tumor-infiltrating B lymphocytes in cancer immunotherapy
by: Shishengnan Song, et al.
Published: (2025-02-01)

Enhancing immunotherapy efficacy in colorectal cancer: targeting the FGR-AKT-SP1-DKK1 axis with DCC-2036 (Rebastinib)
by: Xiguang Chen, et al.
Published: (2025-01-01)

Targeting IL‐17A to manage immunotherapy‐induced toxicity in melanoma
by: Kai Huang
Published: (2025-01-01)

The “Trojan Horse” Approach to Tumor Immunotherapy: Targeting the Tumor Microenvironment
by: Delia Nelson, et al.
Published: (2014-01-01)

Invariant NKT Cells as Novel Targets for Immunotherapy in Solid Tumors
by: Karsten A. Pilones, et al.
Published: (2012-01-01)

Non-small cell lung cancer and the tumor microenvironment: making headway from targeted therapies to advanced immunotherapy
by: Anna De Lucia, et al.
Published: (2025-02-01)

Pan-Cancer Analyses of the Tumor Microenvironment Reveal That Ubiquitin-Conjugating Enzyme E2C Might Be a Potential Immunotherapy Target
by: Guang-zhao Huang, et al.
Published: (2021-01-01)

Integrated bioinformatics and experimental analysis of CHAF1B as a novel biomarker and immunotherapy target in LUAD
by: Wei Du, et al.
Published: (2025-01-01)

Anti-cancer immunotherapy-related cardiotoxicity: preventable and treatable
by: Wu Helena T., et al.
Published: (2025-01-01)

Aptamers: A Feasible Technology in Cancer Immunotherapy
by: M. M. Soldevilla, et al.
Published: (2016-01-01)

Neoantigen immunotherapy: a novel treatment for bladder cancer
by: Ruiyang Lv, et al.
Published: (2025-01-01)